skip to Main Content

A CNIO-led European Study Confirms Diabetes Type 3c as an Early Manifestation of Pancreatic Cancer

A CNIO-led European Study Confirms Diabetes Type 3c as an Early Manifestation of Pancreatic Cancer
As biomedical sciences incorporate increasingly sophisticated methodologies and technologies, our understanding of diseases improves. Diabetes is a clear example since new classifications are being added to the traditional classification into type 1 and type 2 diabetes; these new classifications are based on genetic and molecular characteristics that improve diagnosis and treatment.

The Genetic and Molecular Epidemiology Group, led by Núria Malats at the Spanish National Cancer Research Centre (CNIO), shows the need to continue to improve these classifications: the team published in the journal Gut the results of a European case-control study showing that one of the most recently identified types of diabetes, type 3c or pancreatogenic diabetes, could also be an early manifestation of pancreatic cancer. Read more. . . 


Back To Top